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Abstract—At LLNL and UC Davis, we are developing several 
techniques for the real-time sampling and analysis of trace 
gases, aerosols and exhaled breath that could be useful for a 
modular, integrated system for breath analysis. Those 
techniques include single-particle bioaerosol mass 
spectrometry (BAMS) for the analysis of exhaled aerosol 
particles or droplets as well as breath samplers integrated with 
gas chromatography mass spectrometry (GC-MS) or MEMS-
based differential mobility spectrometry (DMS). We describe 
these techniques and present recent data obtained from human 
breath or breath condensate, in particular, addressing the 
question of how environmental exposure influences the 
composition of breath.   
I. INTRODUCTION 
In recent years, it has been shown that volatile organic 
compounds (VOCs) exhaled in breath have the potential to 
be used as bio-markers for the physiological state of a 
person, systemic diseases (such as cancers and ulcers) as 
well as respiratory diseases [1,2]. As a result breath tests are 
being used for early detection of heart transplant rejection 
[3], stomach ulcers [4], and breast cancer [5]. Nevertheless, 
clinical research on breath analysis is still in its early stages, 
in part, due to limitations in breath analysis instrumentation 
and detector technology. Besides rapid, early medical 
diagnostics, breath VOC analysis may also be useful to 
assess environmental exposure of individuals to solvents 
and other chemicals [6,7]. Currently explored technologies 
for breath analysis include gas chromatography mass 
spectrometry (GC-MS), ion mobility spectrometry (IMS) 
and differential mobility spectrometry (DMS). 
 Aerosol droplets exhaled by human subjects may 
carry tell-tale signatures of respiratory diseases in particular 
when entire intact bacteria or virus are exhaled or coughed-
out in human expirations or sputum. Single particle 
bioaerosol mass spectrometry (BAMS) is applied to human 
expirations and breath analysis where early data suggests 
respiratory infections such as tuberculosis may be detected 
in near real-time analysis of expired human sputum and 
possibly breath. 
In addition to recent instrument technology advances, 
there is a need for future work in signature and bio-marker 
development as well as exploring the correlations between 
disease and environmental exposure of a subject and their 
breath composition (both the VOC and aerosol droplet 
phase). Instrument advances will see the development of 
smaller, more sensitive and deployable breath analysis 
systems that can ideally analyze breath in or near real-time. 
II. METHODS 
A.  Bioaerosol Mass Spectrometry (BAMS) for Aerosol 
Particle Analysis 
Single aerosol particle bioaerosol mass spectrometry 
systems have been developed at LLNL for biodefense 
applications over the last decade and are now being applied 
to the rapid analysis of cells or cell fragments in human 
effluents, such as exhaled aerosols, and screening of those 
effluents for pathogens. The BAMS technique allows 
analyzing the biochemical composition of single aerosol 
particles and cells in real-time and, in some cases, provides 
species discrimination between different species of bacteria 
[8-10]. As shown schematically in Fig. 1, aerosol particles 
are sampled either directly from air or an aerosol generator 
into the inlet of a BAMS system. Particles are 
aerodynamically directed into a tightly focused particle beam 
by means of an aerodynamic lens that also introduces the 
particles into the vacuum of the BAMS mass spectrometer. 
Following the focusing lens and vacuum introduction, 
individual particles are aerodynamically sized by measuring 
their speed using light scattering off several continuous wave 
laser beams. Next, the particles’ fluorescence properties are 
probed by exciting them with a pulsed, low power UV laser. 
When particles reach the ion source of the mass spectrometer 
they are hit by a powerful desorption and ionization laser 
pulse and characteristic molecular ions (both positive and 
negative) are measured by time-of-flight mass spectrometry 
in a bipolar mass spectrometer. The whole analysis process 
takes a fraction of a second per particle. Thus tens of 
particles can be analyzed per second. Little to no sample 
preparation is necessary. 
Using a LLNL BAMS system, we have analyzed 
micrometer sized aerosol droplets comprised of pure bovine 
lung surfactant, water droplets containing single cells of 
Mycobacterium smegmatis (a harmless simulant for M. 
tuberculosis) and droplets of lung surfactant containing 
single cells of M. smegmatis.  
B. Sample preparation for BAMS analysis 
Survanta brand bovine lung surfactant (LS) was obtained 
from Abbott Laboratories and diluted ~1:10 in deionized 
water before aerosolization.  Mycobacterium smegmatis 
(ATCC #19420) was grown in Middlebrook 7H9 broth (BD 
271310) supplemented with 0.2% glycerol and 10% 
albumin-dextrose-catalase (ADC) enrichment (BD 212352).  
Cultures were incubated at 37oC on a platform shaker (150 
rpm) until mid to late log phase and then collected by 
centrifugation. Water-soluble media components were 
removed by washing the pellet x3 with sterile water.  The 
washed pellet was subsequently re-suspended in water to a 
final concentration of 109-1010 cells/mL and refrigerated 
until mass spectral analysis.  Aliquots of the prepared M. 
smegmatis were analyzed within 24 hours of the post-
culturing treatment.   
All liquid suspension samples (lung surfactant - LS, M. 
smegmatis and a mixture of lung surfactant and M. 
smegmatis – LS + M. smeg.) were introduced into the 
BAMS system by aerosolization in a stream of nitrogen gas 
(flow rate ~1.5 L/min) using a low volume disposable 
nebulizer (Salter Labs, Arvin, CA, USA).  Aerosol droplets 
were directed through an in-line diffusion dryer containing a 
silica desiccant resulting in particles with average 
aerodynamic diameter in the range of 0.5-2.5 µm before 
introduction into the mass spectrometer. 
 
C. GC-MS for breath condensate analysis 
      GC-MS is being used at LLNL for the analysis of 
respiratory effluents.  GC-MS is a promising technique 
because of its sensitivity, specificity, and the orthogonal data 
it provides.  Briefly, a sample is introduced to the injection 
point, and is swept through the analytical column by a carrier 
gas, typically helium.  The analytes are separated in time as a 
temperature ramp is induced on the column.  The samples 
are then transferred to the mass spectrometer, where spectra 
are obtained for each eluent.  Using a commercial GC-MS 
system (Agilent 6890A, 5973N) we have conducted a series 
of experiments to explore how this technique can be used to 
assess environmental exposure of an individual by analyzing 
breath or breath condensate.  
D. Sample preparation for breath condensate analysis 
Breath condensate was obtained at each time point by 
breathing into an R-Tube™ breath collection device 
(Respiratory Research, Inc.) with a condenser cooled to -80º 
C for 15 minutes (resulting in ~1mL of condensate) and 
transferring 500 µL aliquots to plastic centrifuge tubes.  
Because of the low concentrations of target compounds in 
breath (nanomolar or lower) [11], solid-phase 
microextraction (SPME) was used to preconcentrate 
samples.  A 65 µm PDMS/DVB Stableflex SPME fiber 
(Sigma-Aldrich, Inc.) was submerged in an aliquot of breath 
condensate for 10 minutes.  The fiber was then placed in the 
injection port of the GC-MS where the sample was thermally 
desorbed from the fiber and subjected to a 17 minute 
temperature program for analysis. 
III. RESULTS 
A. BAMS Results 
The BAMS experiments show that the characteristic 
mass spectral markers observed with BAMS on pure 
Mycobacteria are largely preserved when these bacteria are 
embedded in a complex matrix (bovine lung surfactant) and 
can be used to detect the presence of these bacteria within 
lung surfactant. Fig. 2 shows results obtained with 
Mycobacterium smegmatis, a non-virulent surrogate for M. 
tuberculosis. The three figures depict various m/z ranges 
from the mass spectra measured from pure lung surfactant 
(LS, blue trace), M. smegmatis embedded in LS (black 
trace) and pure M. smegmatis in water (red trace). Note that 
negative m/z values correspond to the mass spectra from 
negative ions (BAMS measures positive and negative ions 
simultaneously by recording the positive and negative ion 
mass spectra in separate channels).  
The data show that characteristic mass spectral peaks 
observed with pure M. smegmatis are conserved when M. 
smegmatis is embedded in lung surfactant and that those 
peaks are clearly distinguishable from the background of 
lung surfactant. Both the positive and negative m/z spectrum 
show an easy distinction between lung surfactant (having 
little ion amplitude) and the stronger mycobacterium ion 
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Fig. 1: Schematic of a LLNL BAMS system. 
signal.  We suggest that the -421 peak is tentatively due to 
the deprotonated disaccharide, trehalose-2-sulfate ion, 
which is a precursor for the sulfolipid virulence factor 
known as sulfolipid 1 (SL-1) [12-14].   SL-1 has been 
positively identified as a component of the virulence factor 
in M. smegmatis and M. tuberculosis H37Ra [15]. These 
data indicate the potential of a BAMS system for detecting 
tuberculosis and other human respiratory diseases within the 
complex background of exhaled human aerosols.  Similar 
experiments using Mycobacteria and other microorganisms 
embedded in human breath condensate or sputum are in 
progress and will help to determine whether BAMS could 
be useful in rapidly diagnosing certain respiratory diseases, 
e.g., tuberculosis.  
 
B. GC-MS Results 
Using a commercial GC-MS system we have conducted 
a series of experiments to explore how this technique can be 
used to assess environmental exposure of an individual by 
analyzing breath or breath condensate. In a preliminary 
study, a subject was asked to donate a breath sample 
immediately before visiting a nail care salon where red nail 
polish was applied.  The subject was then asked to donate 
breath samples after leaving the salon.  Fig. 3 shows the 
results of GC-MS measurements of breath condensates 
sampled before the visit to a nail care salon and application 
of nail polish, 0.75 hours after the salon visit and 3.25 hours 
after.  Note the consistency in all peaks in the spectra before 
time = 7.6 min, which has been tentatively identified as 
camphor.  The data indicate a clearly elevated level of 
camphor (arrow) after the salon visit and a slow decay of the 
camphor signal some hours after.  Although some of the 
camphor in the breath condensate data shown below is 
thought to be due to inhalation of residual chemicals from 
the polished nails, further studies have shown that a 
significant camphor signal is still detected when the inhaled 
air source is moved further away from the polish nails. 
 
IV. CONCLUSIONS 
We have performed single-particle Bioaerosol Mass 
Spectrometry measurements on mycobacteria and 
mycobacteria embedded in bovine lung surfactant. Our 
results indicate that the distinct mass spectral signatures 
observed from pure mycobacteria are largely preserved and 
easily detectable by BAMS when the bacteria are embedded 
in the complex matrix of lung surfactant. Further 
measurements with BAMS that will include M. tuberculosis 
H37Ra (an avirulent strain) are in progress and will help to 
evaluate the potential use of BAMS in real-time biomedical 
diagnostics for respiratory diseases such as tuberculosis.  
We also have performed measurements on exhaled 
human breath condensate using GC-MS analysis to 
 
 
Fig. 2:  Mycobacterium smegmatis detection in a background 
of bovine lung surfactant with bioaerosol mass spectrometry 
(BAMS).  The three graphs show different m/z ranges. 
Average m/z spectra are shown: ~900 particles each of M. 
smeg and lung surfactant, respectively, and ~600 particles of 
M. smeg. embedded in lung surfactant.  The peak at m/z = -421 
is tentatively assigned as the deprotonated disaccharide, 
trehalose-2-sulfate ion which is a precursor for the SL-1 
virulence factor found in both M. smegmatis and M. 
tuberculosis. 
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Fig. 3: Breath condensate sample extracted with a SPME fiber 
for 10 minutes and run with a GC-MS.  All three traces are 
from the same subject.  The top trace sample was obtained 
before having a manicure with red nail polish in a nail salon, 
the two other traces were obtained at 0.75 hours and 3.25 hours 
after the salon visit, respectively.  Note the new compound at 
7.6 min (arrow).  This compound has been identified as 
camphor, a known environmental hazard in nail salons.  
investigate whether trace VOCs in human breath can be 
used to detect environmental exposure of a person to certain 
chemicals some time after the exposure. Our initial results 
are encouraging and indicate that markers for environmental 
exposure may exist for days after the exposure.  
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